AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 93 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.8% | 3,771 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 3,771 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 3,771 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 3,771 | +101.5% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 1,871 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 1,871 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | +600.0% | 1,871 | +353.0% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 413 | +61.3% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 256 | -39.5% | 0.00% | – |
| Q1 2020 | $3,000 | – | 423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,887,535 | $37,128,000 | 4.83% |
| FT Options LLC | 190,400 | $1,451,000 | 2.19% |
| DAFNA Capital Management LLC | 135,738 | $2,670,000 | 1.66% |
| Nantahala Capital Management | 1,367,947 | $26,908,000 | 1.32% |
| Perceptive Advisors | 3,260,000 | $64,124,000 | 1.22% |
| EAM Investors, LLC | 235,470 | $4,632,000 | 0.62% |
| 361 CAPITAL LLC | 139,489 | $2,744,000 | 0.53% |
| Opus Point Partners Management, LLC | 21,009 | $413,000 | 0.37% |
| EAGLE ASSET MANAGEMENT INC | 3,043,867 | $59,629,000 | 0.34% |
| Piermont Capital Management Inc. | 27,770 | $546,000 | 0.18% |